Spontaneous activation of the lytic cycle in cells infected with a recombinant Kaposi's sarcoma-associated virus

被引:22
作者
Delecluse, HJ [1 ]
Kost, M
Feederle, R
Wilson, L
Hammerschmidt, W
机构
[1] Univ Birmingham, Dept Pathol, CRC, Inst Canc Studies, Birmingham B15 2TT, W Midlands, England
[2] GSF, Natl Res Ctr Environm & Hlth, Dept Gene Vectors, D-81377 Munich, Germany
关键词
D O I
10.1128/JVI.75.6.2921-2928.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The genetic analysis of human herpesvirus 8 (HHV8), also termed Kaposi's sarcoma-associated virus, has been hampered by severe difficulties in producing infectious viral particles and modifying the viral genome. In this article, we report the successful cloning of the HHV8 complete genome onto a prokaryotic F-plasmid replicon which allows the propagation of the recombinant viral DNA in Escherichia coli. The insertion of the F-plasmid into the HNV8 genome interrupts the ORF56 gene, whose expression product--by homology with the Epstein-Barr virus BSLF1 gene--is supposed to be necessary for lytic DNA replication. After introduction of the recombinant HHV8 DNA into 293 cells, early viral antigens are expressed, suggesting that spontaneous lytic replication is initiated. However, completion of the lytic program is prevented by the absence of the ORF56 protein, and a quasi-latent state is established, Upon reintroduction of the ORF56 viral gene, the block is overcome and infectious HHV8 virions are produced. As the recombinant HHV8 genome can be easily modified in E. coli, this experimental system opens the way to an extensive genetic analysis of other HHV8 functions.
引用
收藏
页码:2921 / 2928
页数:8
相关论文
共 27 条
[1]   Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation [J].
Arvanitakis, L ;
GerasRaaka, E ;
Varma, A ;
Gershengorn, MC ;
Cesarman, E .
NATURE, 1997, 385 (6614) :347-350
[2]   Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus [J].
Arvanitakis, L ;
Mesri, EA ;
Nador, RG ;
Said, JW ;
Asch, AS ;
Knowles, DM ;
Cesarman, E .
BLOOD, 1996, 88 (07) :2648-2654
[3]   G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator [J].
Bais, C ;
Santomasso, B ;
Coso, O ;
Arvanitakis, L ;
Raaka, EG ;
Gutkind, JS ;
Asch, AS ;
Cesarman, E ;
Gerhengorn, MC ;
Mesri, EA .
NATURE, 1998, 391 (6662) :86-89
[4]   Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines [J].
Boshoff, C ;
Endo, Y ;
Collins, PD ;
Takeuchi, Y ;
Reeves, JD ;
Schweickart, VL ;
Siani, MA ;
Sasaki, T ;
Williams, TJ ;
Gray, PW ;
Moore, PS ;
Chang, Y ;
Weiss, RA .
SCIENCE, 1997, 278 (5336) :290-294
[5]   A first-generation packaging cell line for Epstein-Barr virus-derived vectors [J].
Delecluse, HJ ;
Pich, D ;
Hilsendegen, T ;
Baum, C ;
Hammerschmidt, W .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (09) :5188-5193
[6]   Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells [J].
Delecluse, HJ ;
Hilsendegen, T ;
Pich, D ;
Zeidler, R ;
Hammerschmidt, W .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (14) :8245-8250
[7]   LATENT MAREKS-DISEASE VIRUS CAN BE ACTIVATED FROM ITS CHROMOSOMALLY INTEGRATED STATE IN HERPESVIRUS-TRANSFORMED LYMPHOMA-CELLS [J].
DELECLUSE, HJ ;
SCHULLER, S ;
HAMMERSCHMIDT, W .
EMBO JOURNAL, 1993, 12 (08) :3277-3286
[8]   Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma [J].
Dupin, N ;
Fisher, C ;
Kellam, P ;
Ariad, S ;
Tulliez, M ;
Franck, N ;
van Marck, E ;
Salmon, D ;
Gorin, I ;
Escande, JP ;
Weiss, RA ;
Alitalo, K ;
Boshoff, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (08) :4546-4551
[9]   The URNA genes of herpesvirus saimiri (strain C488) are dispensable for transformation of human T cells in vitro [J].
Ensser, A ;
Pfinder, A ;
Müller-Fleckenstein, I ;
Fleckenstein, B .
JOURNAL OF VIROLOGY, 1999, 73 (12) :10551-10555
[10]   TRANS-ACTING REQUIREMENTS FOR REPLICATION OF EPSTEIN-BARR-VIRUS ORI-LYT [J].
FIXMAN, ED ;
HAYWARD, GS ;
HAYWARD, SD .
JOURNAL OF VIROLOGY, 1992, 66 (08) :5030-5039